Precise genome editing: the key to a CRISPR drug discovery pipeline?
Posted in Archive
| Tagged Academic, AI / data analytics / healthtech / informatics, Analysis, Animal models, Assay development optimisation & technology, Biochemistry, Business, Cell therapy, Cellular & Molecular biology, Cellular assays, Chemical engineering, Chemistry, Clinical specialities, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics, Genetics / genomes, Genetics / genomics, Genomics, High Content Screening, High throughput screening, Imaging, Immunology, Lead discovery, Lead optimisation, Metabolomics, Molecular medicine, Oncology, PCR, Pharmacology, Precision medicine, Preclinical, Protein chemistry / Proteomics, RNA, Screening, Sequencing, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Translational, Translational chemistry
